| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |